BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38890190)

  • 1. AKR1C4 regulates the sensitivity of colorectal cancer cells to chemotherapy through ferroptosis modulation.
    Wang L; Lv C; Liu X
    Cancer Chemother Pharmacol; 2024 Jun; ():. PubMed ID: 38890190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosis.
    Huang Y; Yang W; Yang L; Wang T; Li C; Yu J; Zhang P; Yin Y; Li R; Tao K
    Sci Rep; 2023 Sep; 13(1):14359. PubMed ID: 37658132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMEM120A-mediated regulation of chemotherapy sensitivity in colorectal cancer cells.
    Wang L; Liu X
    Cancer Chemother Pharmacol; 2024 Jan; 93(1):11-22. PubMed ID: 37728615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esculin induces endoplasmic reticulum stress and drives apoptosis and ferroptosis in colorectal cancer via PERK regulating eIF2α/CHOP and Nrf2/HO-1 cascades.
    Ji X; Chen Z; Lin W; Wu Q; Wu Y; Hong Y; Tong H; Wang C; Zhang Y
    J Ethnopharmacol; 2024 Jun; 328():118139. PubMed ID: 38561058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches.
    Cheng X; Zhao F; Ke B; Chen D; Liu F
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in Colorectal Cancer.
    Zeng K; Li W; Wang Y; Zhang Z; Zhang L; Zhang W; Xing Y; Zhou C
    Adv Sci (Weinh); 2023 Sep; 10(25):e2301088. PubMed ID: 37428466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
    Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
    Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL17 coordinates ferroptosis and tumorigenesis by regulating mitochondrial translation in colorectal cancer.
    Li H; Yu K; Hu H; Zhang X; Zeng S; Li J; Dong X; Deng X; Zhang J; Zhang Y
    Redox Biol; 2024 May; 71():103087. PubMed ID: 38377789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNHG4-mediated PTEN destabilization confers oxaliplatin resistance in colorectal cancer cells by inhibiting ferroptosis.
    Li SQ; Xu WT; Yin YX; Wei HT; Li KZ; Xie MZ; Lv F; Xie LY; Hu BL
    Apoptosis; 2024 Jun; 29(5-6):835-848. PubMed ID: 38573492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipocyte-Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer.
    Zhang Q; Deng T; Zhang H; Zuo D; Zhu Q; Bai M; Liu R; Ning T; Zhang L; Yu Z; Zhang H; Ba Y
    Adv Sci (Weinh); 2022 Oct; 9(28):e2203357. PubMed ID: 35978266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting PTGES/PGE2 axis enhances sensitivity of colorectal cancer cells to 5-fluorouracil.
    Geng S; Zhan H; Cao L; Geng L; Ren X
    Biochem Cell Biol; 2023 Dec; 101(6):501-512. PubMed ID: 37358009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A machine learning and drug repurposing approach to target ferroptosis in colorectal cancer stratified by sex and KRAS.
    Yan H; Shen X; Yao Y; Khan SA; Ma S; Johnson CH
    bioRxiv; 2024 Jun; ():. PubMed ID: 38979294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
    Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T
    Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771
    [No Abstract]   [Full Text] [Related]  

  • 14. HTRA1 interacts with SLC7A11 to modulate colorectal cancer chemosensitivity by inhibiting ferroptosis.
    Liu W; Liu C; Xiao J; Qian C; Chen Z; Lin W; Zhang Y; Wu J; Zhou R; Zhao L
    Cell Death Discov; 2024 May; 10(1):228. PubMed ID: 38740771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin.
    Yang C; Zhang Y; Lin S; Liu Y; Li W
    Aging (Albany NY); 2021 Mar; 13(10):13515-13534. PubMed ID: 33819186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer.
    Wang G; Wang JJ; Zhi-Min Z; Xu XN; Shi F; Fu XL
    Sci Prog; 2023; 106(1):368504221147173. PubMed ID: 36718538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
    Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
    Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
    Hu J; Cai G; Xu Y; Cai S
    Curr Mol Med; 2016; 16(1):70-82. PubMed ID: 26695693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of GCH1/BH4 Axis Activates Ferritinophagy to Mitigate the Resistance of Colorectal Cancer to Erastin-Induced Ferroptosis.
    Hu Q; Wei W; Wu D; Huang F; Li M; Li W; Yin J; Peng Y; Lu Y; Zhao Q; Liu L
    Front Cell Dev Biol; 2022; 10():810327. PubMed ID: 35223839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferroptosis in colorectal cancer: a future target?
    Yan H; Talty R; Aladelokun O; Bosenberg M; Johnson CH
    Br J Cancer; 2023 Apr; 128(8):1439-1451. PubMed ID: 36703079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.